Mikhail Paveliev

Title: Mikhail Paveliev: Innovator in Neuronal Injury Treatment

Introduction

Mikhail Paveliev is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of neuroscience, particularly in the treatment of neuronal injuries. With a total of two patents to his name, Paveliev is recognized for his innovative approaches to promoting neural regeneration.

Latest Patents

Paveliev's latest patents focus on the use of protamine in the treatment of neuronal injuries. The inventions disclose novel methods for promoting neurite outgrowth and neural regeneration in central nervous system (CNS) injuries. A key aspect of his work involves a novel mechanism that enhances the interaction of chondroitin sulphate proteoglycan (CSPG) with receptor protein tyrosine phosphatase sigma (RPTPσ), which is crucial for promoting neurite outgrowth.

Career Highlights

Mikhail Paveliev is affiliated with the University of Helsinki, where he conducts his research and development work. His academic background and ongoing research contribute to advancements in the treatment of neuronal injuries, making him a valuable asset to the scientific community.

Collaborations

Paveliev collaborates with esteemed colleagues such as Heikki Rauvala and Juha Kuja-Panula. Their combined expertise fosters a productive research environment that enhances the potential for groundbreaking discoveries in neuroscience.

Conclusion

Mikhail Paveliev's innovative work in the treatment of neuronal injuries showcases his dedication to advancing medical science. His patents reflect a commitment to improving outcomes for individuals suffering from CNS injuries.